Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Ibio Inc (IBIO)

Ibio Inc (IBIO)
0.7003 x 8 0.7190 x 153
Post-market by (Cboe BZX)
0.7000 -0.1500 (-17.65%) 04/22/25 [NASDAQ]
0.7003 x 8 0.7190 x 153
Post-market 0.7197 +0.0197 (+2.81%) 19:58 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.6400
Day High
1.0000
Open 1.0000
Previous Close 0.8500 0.8500
Volume 9,177,400 9,177,400
Avg Vol 1,150,275 1,150,275
Stochastic %K 0.86% 0.86%
Weighted Alpha -58.82 -58.82
5-Day Change -0.4800 (-40.68%) -0.4800 (-40.68%)
52-Week Range 0.6358 - 6.8908 0.6358 - 6.8908
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,372
  • Shares Outstanding, K 9,875
  • Annual Sales, $ 230 K
  • Annual Income, $ -24,910 K
  • EBIT $ -16 M
  • EBITDA $ -14 M
  • 60-Month Beta 1.02
  • Price/Sales 39.06
  • Price/Cash Flow N/A
  • Price/Book 0.63
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.65
  • Most Recent Earnings $-0.48 on 02/10/25
  • Next Earnings Date 05/12/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.39
  • Number of Estimates 1
  • High Estimate -0.39
  • Low Estimate -0.39
  • Prior Year -0.71
  • Growth Rate Est. (year over year) +45.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6358 +10.10%
on 04/22/25
Period Open: 4.6300
4.8600 -85.60%
on 03/25/25
-3.9300 (-84.88%)
since 03/21/25
3-Month
0.6358 +10.10%
on 04/22/25
Period Open: 3.0700
6.8908 -89.84%
on 03/03/25
-2.3700 (-77.20%)
since 01/22/25
52-Week
0.6358 +10.10%
on 04/22/25
Period Open: 1.7800
6.8908 -89.84%
on 03/03/25
-1.0800 (-60.67%)
since 04/22/24

Most Recent Stories

More News
iBio Expands Cardiometabolic and Obesity Pipeline through Licensing of First-in-Class Antibody Targeting Activin E from AstralBio

IBIO : 0.7000 (-17.43%)
iBio Stock Plummets Despite Positive Data On Weight-Loss Treatment Antibody: Retail Stays Bearish

However, the company said that the study does not prove statistical significance and only involves a single administration of the antibody.

VXF : 162.43 (+2.71%)
DFAT : 47.67 (+2.49%)
IBIO : 0.7000 (-17.43%)
iBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline

IBIO : 0.7000 (-17.43%)
iBio to Begin Trading on the Nasdaq Stock Exchange

IBIO : 0.7000 (-17.43%)
iBio Reports Fiscal Second Quarter 2025 Financial Results

IBIO : 0.7000 (-17.43%)
iBio Announces New Investments from Board Members and Officers

IBIO : 0.7000 (-17.43%)
iBio Discovers Novel Antibody Targeting Activin E in Collaboration with AstralBio

IBIO : 0.7000 (-17.43%)
iBio Expands Cardiometabolic and Obesity Program with Anti-Myostatin Antibody Discovered Using its Proprietary Platform, In-Licensed from AstralBio

IBIO : 0.7000 (-17.43%)
iBio Strengthens Board with Appointment of Two New Independent Directors

IBIO : 0.7000 (-17.43%)
iBio Reports Fiscal First Quarter 2025 Financial Results

IBIO : 0.7000 (-17.43%)

Business Summary

Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch platform technology. The Company's hydroponically grown green plants can be used for the development and manufacture...

See More

Key Turning Points

3rd Resistance Point 1.2856
2nd Resistance Point 1.1428
1st Resistance Point 0.9214
Last Price 0.7000
1st Support Level 0.5572
2nd Support Level 0.4144
3rd Support Level 0.1930

See More

52-Week High 6.8908
Fibonacci 61.8% 4.5014
Fibonacci 50% 3.7633
Fibonacci 38.2% 3.0252
Last Price 0.7000
52-Week Low 0.6358

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro